80214-83-1
837.1
C41H76N2O15
Soluble in HCl and NaOH
+4°C
*Please inquire the availability for this product. Roxithromycin was one of the new generation erythromycins introduced in the 1980s. Improved acid stability was achieved by converting the 9-keto group to the more stable oxime and alkylation of the oxime to provide the methoxyethoxymethyl ether oxime. In vivo, roxithromycin exhibits higher tissue levels and a longer half-life while being slightly less potent than erythromycin in vitro.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
